+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Erythropoietin Drugs - Global Strategic Business Report - Product Thumbnail Image

Erythropoietin Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 179 Pages
  • Global
From
Hepatitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Hepatitis Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 298 Pages
  • Global
From
End-Stage Renal Disease - Global Strategic Business Report - Product Thumbnail Image

End-Stage Renal Disease - Global Strategic Business Report

  • Report
  • September 2025
  • 174 Pages
  • Global
From
Potassium Citrate - Global Strategic Business Report - Product Thumbnail Image

Potassium Citrate - Global Strategic Business Report

  • Report
  • September 2025
  • 182 Pages
  • Global
From
Hepatitis C Treatment - Global Strategic Business Report - Product Thumbnail Image

Hepatitis C Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 208 Pages
  • Global
From
From
From
From
Renal Anemia Treatment - Global Strategic Business Report - Product Thumbnail Image

Renal Anemia Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 278 Pages
  • Global
From
Liver Disease Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Liver Disease Diagnostics - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
From
Pyelonephritis - Pipeline Insight, 2025 - Product Thumbnail Image

Pyelonephritis - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Focal Segmental Glomerulosclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Focal Segmental Glomerulosclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
From
Renal Anemia- Pipeline Insight, 2025 - Product Thumbnail Image

Renal Anemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Lupus Nephritis - Pipeline Insight, 2025 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Hepatitis D - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis D - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Hepatitis A - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis A - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more